ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Larimar Therapeutics Reports FDA Clinical Hold on CTI-1601 and Termination of Recently Announced Private Placement Financing
May 26, 2021Larimar today announced that the United States Food and Drug Administration (FDA) has placed a clinical hold on the CTI-1601 clinical program and that the company will not be closing a previously announced private placement financing. -
Early Trial Offers New Hope for People With Hemophilia
September 18, 2020Researchers may have found a way for people with severe hemophilia to take their standard treatment less often, if the results of an early trial pan out. -
Proclara Biosciences Australia awarded grant to help develop new biotherapy with blockbuster potenti
March 14, 2017Work on a second-generation fusion protein due to start in 2017 at Patheon's manufacturing facility in Brisbane.
Pharma Sources Insight January 2025
